Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New quick MRI could speed up brain tumor diagnosis in kids

NCT ID NCT05776602

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested a new, fast MRI sequence called Neuromix in 32 children with suspected or confirmed brain tumors. The goal was to see if the quick scan works as well as the standard, longer MRI. If it does, it could make scanning easier and less stressful for children.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Fast MRI (Neuromix) diagnostic test
What this could lead to
If successful, this fast MRI could make brain tumor diagnosis quicker and easier for children, reducing the need for long scans or sedation.
What could go wrong
This is a small, completed study with only 32 children, so results may not apply to all patients. The fast MRI may not be as accurate as the standard scan.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

32 people

The number who actually took part.

Started

May 2023

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Children up to 18 years with suspected or confirmed brain tumor investigated in standard clinical care with MRI of the brain.

Ages

1 month to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 0-18 years. * Pediatric subjects with diagnosed or suspected brain tumor * Referral routine MRI study. Exclusion Criteria: * MRI planned without sedation * Aborted MR exam * Unstable patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brain neoplasms are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Karolinksa Universitetssjukhuset

    Stockholm, Stockholm County, Eugeniavägen 3, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.